BETA-LACTAMYL VASOPRESSIN V1AANTAGONISTS,申请号CA20022462903-传众专利搜索

发明名称	BETA-LACTAMYL VASOPRESSIN V1AANTAGONISTS
摘要	Novel 2-(azetidin-2-on-1-yl)alkanedioic acid derivatives and 2-(azetidin-2-o n- l-yl)alkoxyalkanoic acid derivatives are described for use in the treatment of disease states responsive to antagonism of the vasopressin Vla receptor.</SD OAB>
申请公布号	CA2462903(A1)	申请公布日期	2003.04.17
申请号	CA20022462903	申请日期	2002.10.11
申请人	SERENIX PHARMACEUTICALS, LLC.	发明人	MILLER, MARVIN, J.;GUILLON, CHRISTOPHE D. G.;HEINDEL, NED D.;KOPPEL, GARY, A.;BRUNS, ROBERT F., JR.
分类号	C07D413/04;A61K31/4178;A61K31/422;A61K31/4439;A61K31/454;A61K31/4725;A61K31/496;A61K31/5377;A61K31/551;A61P1/02;A61P1/04;A61P1/06;A61P1/08;A61P1/12;A61P3/10;A61P7/00;A61P9/00;A61P9/08;A61P9/10;A61P11/00;A61P11/02;A61P11/06;A61P13/02;A61P13/08;A61P13/10;A61P15/00;A61P17/00;A61P17/04;A61P17/06;A61P19/00;A61P19/02;A61P19/04;A61P19/08;A61P19/10;A61P21/00;A61P25/00;A61P25/04;A61P25/06;A61P25/08;A61P25/16;A61P25/18;A61P25/22;A61P25/24;A61P25/28;A61P25/32;A61P25/36;A61P27/02;A61P29/00;A61P29/02;A61P31/18;A61P35/00;A61P37/02;A61P37/06;A61P37/08;A61P43/00;C07D401/14;C07D403/04;C07D403/14;C07D409/14;C07D413/02;C07D413/14;C07D417/14;(IPC1-7):C07D413/04;C07D405/06;C07D409/06;A61K31/402	主分类号	C07D413/04
代理机构		代理人
主权项
地址